Fermenta Biotech Limited Q4 FY26 results deck summary

Results deck of 26 May 2026, summarised by AI from the filing.

FY26 revenue ₹547.8 cr, up 14% YoY; ex-real estate revenue ₹546 cr, up 27% YoY.

Key takeaways

1. FY26 revenue FY26 revenue ₹547.8 cr, up 14% YoY; ex-real estate revenue ₹546 cr, up 27% YoY.
2. Real estate base FY26 headline decline reflects high FY25 base from real estate value unlocking (₹45 cr in FY25 vs ₹2 cr in FY26).
3. Growth drivers Vitamin D3 Human Nutrition +28% YoY at ₹293 cr; Animal Nutrition +32% YoY at ₹109 cr; Green Chemistry +126% YoY at ₹16 cr.
4. Debt Total debt held at ₹109 cr; debt-to-equity down to 0.27 from 0.30.

Original filing on BSE

Fermenta Biotech Limited Q1 FY27 results

As filed: Revenue ₹112 cr, EBITDA ₹23.0 cr, PAT ₹15.0 cr, EBITDA margin 20.6%.

Not scored. No result for the same quarter last year.

Fermenta Biotech Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Results deck (11 Aug 2026), Results press release (11 Aug 2026)
• Q4 FY26: Results deck (26 May 2026), Results press release (26 May 2026)
• Q3 FY26: Results deck (11 Feb 2026), Results press release (9 Feb 2026)
• Q2 FY26: Results deck (12 Nov 2025), Results press release (11 Nov 2025)
• Q1 FY26: Results deck (13 Aug 2025)
• Q4 FY25: Results deck (4 Jun 2025), Results press release (28 May 2025)